CrushSCI.com
111.3Average days
92Median days
22Fastest days
208Longest days
1322025 publications

Paper Review Records

All Paper Review Records

6 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

66 days

Autologous chondrocyte implantation for the knee: Historical development, age-related outcomes, and future directions

Authors
Kyohei Nakata; Akinori Nekomoto; Atsuo Nakamae; Nobuo AdachiShow moreShow less
Affiliations
1. Department of Orthopaedic Surgery, Graduate School of Biomedical & Health Sciences, Hiroshima University , Hiroshima ,; 2. Department of Musculoskeletal Reconstruction and Biomaterials, Graduate School of Biomedical & Health Sciences, Hiroshima University , Hiroshima ,Show moreShow less
Source PDF DOI Publisher page
49 days

The evolutionary trade-off between immunosurveillance and self-tolerance: Insights from four rheumatologic themes

Authors
Masaru Kato; Masatoshi Kawataka; Satoshi Yamaguchi; Reina Tsuda; Yoshitomo Morinaga; Tatsuhiko Ozawa; Shiho FujisakaShow moreShow less
Affiliations
1. The First Department of Internal Medicine, Faculty of Medicine, University of Toyama , Toyama ,; 2. Department of Rheumatology and Kampo Medicine, Toyama Prefectural Central Hospital , Toyama ,; 3. Department of Microbiology, Faculty of Medicine, Academic Assembly, University of Toyama , Toyama ,; 4. Department of Life Sciences and Bioengineering, Laboratory of Molecular and Cellular Biology, Faculty of Engineering, Academic Assembly, University of Toyama , Toyama ,; 5. Center for Advanced Antibody Drug Development, University of Toyama , Toyama ,Show moreShow less
Source PDF DOI Publisher page
208 days

Exploring brain metabolism and cognitive impairment in childhood-onset systemic lupus using fluorodeoxyglucose positron emission tomography

Authors
Flávia Patrícia Sena Teixeira Santos; Gilda Aparecida Ferreira; Alexei Manso Machado; Jonas Jardim de Paula; Kalline Cristina Prata De Souza; Lucas Teles de Carvalho Godoy Sampaio; Marcelo Mamede; Carlos Malamut; Humberto CorreaShow moreShow less
Affiliations
1. Division of Rheumatology, Hospital das Clínicas da Universidade Federal de Minas Gerais (UFMG) , Belo Horizonte ,; 2. Department of the Locomotor Apparatus, Universidade Federal de Minas Gerais (UFMG) , Belo Horizonte ,; 3. Department of Anatomy and Imaging, School of Medicine, Universidade Federal de Minas Gerais (UFMG) , Belo Horizonte ,; 4. Department of Psychology, Faculdade de Ciências Médicas de Minas Gerais , Belo Horizonte ,; 5. Department of the Locomotor Apparatus, Post graduation Program in Molecular Medicine, Universidade Federal de Minas Gerais (UFMG) , Belo Horizonte ,; 6. Department of Psychology, Faculdade de Ciências Médicas de Minas Gerais, Nuclear Technology Development Center, Nuclear Energy National Commission (CDTN/CNEN) ,; 7. Department of Mental Health, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG) , Belo Horizonte ,Show moreShow less
Source PDF DOI Publisher page
22 days

Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: Long-term efficacy and safety through 5 years in the SELECT-EARLY study

Authors
Tsutomu Takeuchi; Ronald van Vollenhoven; Yukitaka Ueki; Tatsuya Atsumi; Sebastian Meerwein; Xianwei Bu; Kazuya Hirata; Vibeke StrandShow moreShow less
Affiliations
1. Keio University School of Medicine , Tokyo ,; 2. Saitama Medical University , Saitama ,; 3. Amsterdam University Medical Center , Amsterdam ,; 4. Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital , Sasebo, Nagasaki ,; 5. Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University , Sapporo ,; 6. AbbVie Inc. , North Chicago, IL ,; 7. AbbVie GK , Tokyo ,; 8. Division of Immunology and Rheumatology, Stanford University , Palo Alto, CA ,Show moreShow less
Source PDF DOI Publisher page
205 days

Patient-reported outcomes in patients with rheumatoid arthritis treated with baricitinib: A prospective observational study in Japan

Authors
Yuko Kaneko; Naoto Tsujimoto; Izumi Sato; Taisuke Kojima; Kei IkedaShow moreShow less
Affiliations
1. Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine , 35 Shinanomachi, Shinjuku-ku, Tokyo ,; 2. Japan Drug Development & Medical Affairs, Eli Lilly Japan K.K. , Kobe ,; 3. Department of Rheumatology/Rheumatic Disease Center, Dokkyo Medical University , 880 Kitakobayashi, Mibu, Shimotsugagun, Tochigi ,Show moreShow less
Source PDF DOI Publisher page
118 days

Decrease of Infectious Complications in Outpatients With Autoimmune Diseases From 2019 to 2020 Under the COVID-19 Pandemic: A Single-Center, Retrospective Cohort Study in Japan

Authors
Yumiko Oka; Takao Kodera; Miki Takeshita; Yuko Shirota; Tomoki Takeda; Tomomi Tsutsumi; Junichi KameokaShow moreShow less
Affiliations
1. Department of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Miyagi, JapanShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Modern Rheumatology take to review a manuscript?

As of 2026-11-19, CrushSCI has 6 complete review records for Modern Rheumatology. The fastest paper went from submission to acceptance in 22 days (Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: Long-term efficacy and safety through 5 years in the SELECT-EARLY study, received 2026-02-12, accepted 2026-03-06); the slowest took 208 days. The average is 111.3 days and the median is 92 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.